SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-032416
Filing Date
2021-03-05
Accepted
2021-03-05 08:31:32
Documents
12
Period of Report
2021-03-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm218804d1_8k.htm   iXBRL 8-K 24509
  Complete submission text file 0001104659-21-032416.txt   195743

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20210301.xsd EX-101.SCH 3178
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20210301_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20210301_pre.xml EX-101.PRE 22705
5 EXTRACTED XBRL INSTANCE DOCUMENT tm218804d1_8k_htm.xml XML 3514
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 21716613
SIC: 2834 Pharmaceutical Preparations